Stock Alert: Esports Entertainment Rises 25%

By RTTNews Staff Writer   ✉   | Published:

Shares of Esports Entertainment Group, Inc. (GMBL) are gaining nearly 25% on Monday morning despite no-stock related news to drive the shares.

US stocks gained on Monday morning, as oil prices increased and investors expect new round of stimulus spending will strengthen the economy.

GMBL is currently trading at $9.60, up $1.88 or 24.35%, on the Nasdaq.

Esports Entertainment operates as an online gambling company in Canada. The company offers esports , esports wagering, and iGaming and traditional sports betting services, as well as professional and amateur esports events.

For comments and feedback contact: editorial@rttnews.com

Business News

Previous Story
Next Story
Editors Pick
Amazon Workers In Alabama To Start Mail Ballots For Unionization Vote
Amazon warehouse workers in Alabama are starting their mail-in voting on unionization Monday after the National Labor Relations Board or NLRB rejected the company's request for a delay in election. The regulator will mail ballots to around 6,000 workers at the warehouse starting Monday to decide whether to unionize, and the ballots must be returned by March 29.
FDA OKs Bristol-Myers Squibb's Breyanzi To Treat Large-B-Cell Lymphoma
The U.S. Food and Drug Administration approved a new treatment for adult patients with certain types of large B-cell lymphoma (LBCL) who have not responded to, or who have relapsed after, at least two other types of systemic treatment. Bristol-Myers Squibb's Breyanzi (lisocabtagene maraleucel) is the third gene therapy to be approved by the FDA for Large-B-Cell Lymphoma.
AstraZeneca Vaccine Rollout Halted In South Africa
South Africa has halted the rollout of AstraZeneca- Oxford vaccine against Covid-19 after a study showed the vaccine provided minimal protection against a new variant. South African Health Minister Zweli Mkhize, while speaking at a news conference on Sunday, said there is a temporary hold as the government waits for further advice on how to proceed with the AstraZeneca- Oxford vaccine...